Effect of JNK inhibition on cisplatin-induced renal damage

Nephrology Dialysis Transplantation

Volumn 22, Issue 8, 2007, Pages 2138-2148

  Francescato, Heloísa D C ^a   Costa, Roberto S ^a   Júnior, Fernando Barbosa ^a   Coimbra, Terezila M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute renal failure; Apoptosis; C jun N terminal kinase; Cisplatin; Inflammation; SP600125

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CISPLATIN; CREATININE; MACROGOL; POTASSIUM; SODIUM; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY TUBULE CELL; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; URINALYSIS; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ANTHRACENES; APOPTOSIS; CISPLATIN; GLOMERULAR FILTRATION RATE; INFLAMMATION; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MAP KINASE KINASE 4; NECROSIS; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR;

EID: 34547830313     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm144     Document Type: Article

References (51)

1. Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner Electrolyte Metab 1994; 20: 201-213
2. Blachley JD, Hill JB. Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981; 95: 628-632
3. Chopra S, Kaufman JS, Jones TW et al. Cis-diamminedichloro-platinum-induced acute renal failure in the rat. Kidney Int 1982; 21: 54-64
4. Leibbrandt ME, Wolfgang GH, Metz AL, Ozobia AA, Haskins JR. Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. Kidney Int 1995; 48: 761-770
5. Safirstein R, Miller P, Dikman S, Lyman N, Shapiro C. Cisplatin nephrotoxicity in rats: Defect in papillary hypertonicity. Am J Physiol 1981; 241: F175-F185
6. Francescato HDC, Coimbra TM, Costa RS, Bianchi MLP. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis. Kidney Blood Press Res 2004; 27: 148-158
7. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis. Am J Physiol 1996; 270: F700-F708
8. Xiao T, Choudhary S, Zhang W, Ansari NH, Salahudeen A. Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells. J Toxicol Environ Health A 2003; 66: 469-479
9. Taguchi T, Nazneen A, Ruhul-Abid M, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005; 148: 107-121
10. Hannemann J, Baumann K. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study. Arch Toxicol 1990; 64: 393-400
11. Zhong LF, Zhang JG, Zhang M, Ma SL, Xia YX. Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats. Arch Toxicol 1990; 64: 599-600
12. Sheikh-Hamad D, Cacini W, Buckley AR et al. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 2004; 78: 147-155
13. Bokemeyer D, Sorokin A, Dunn MJ. Multiple intracellular MAP quinase signaling cascades. Kidney Int 1996; 49: 1187-1198
14. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK- p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331
15. Sluss HK, Barrett T, Derijard B, Davis RJ. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 1994; 14: 8376-8384
16. Verheij M, Bose R, Lin XH et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-79
17. Yokoo T, Kitamura M. Unexpected protection of glomerular mesangial cells from oxidant-triggered apoptosis by bioflavonoid quercetin. Am J Physiol 1997; 273: F206-F212
18. Ishikawa Y, Yokoo T, Kitamura M. c-Jun/AP-1, but not NF-κB, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells. Biochem Biophys Res Comm 1997; 240: 496-501
19. Ishikawa. Y, Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK- mediated apoptotic pathways. Kidney Int 2000; 58: 1078-1087
20. Ferrandi C, Ballerio R, Gaillard P et al. Inhibition of c-jun-N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Brit J Pharm 2004; 142: 953-960
21. Derijard B, Hibi M, Wu IH et al. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-1037
22. Kallunki T, Su B, Tsigelny I et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 1994; 8: 2996-3007
23. Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: All roads lead to AP-1. J Leukoc Biol 1998; 63: 139-152
24. Von Knethen A, Callsen D, Brune B. NF-kappa B and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 1999; 10: 361-372
25. Pendas AM, Balbin M, Llano E, Jimenez MG, Lopez-Otin C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 1997; 40: 22-233
26. Bennett BL, Sasaki DT, Murray BW et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13686
27. Schnabl B, Bradham CA, Bennett BL, Manning AM, Stefanovic B, Brenner DA. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology 2001; 34: 953-963
28. Wang Y, Li C, Wang X, Zhang J, Chang Z. Heat shock response inhibits IL-18 expression through the JNK pathway in murine peritoneal macrophages. Biochem Biophys Res Commun 2002; 296: 742-748
29. 2-terminal kinase in allergic airway inflammation and remodeling: Effects of SP600125. Eur J Pharm 2005; 506: 273-283
30. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-474
31. Eardley SK, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455
32. Füehr Y, Kaczmarszk Y, Kruttgen GD. Eine einfache colorimetrische Methode zur Inulin Bestimmung für Nieren Clearance-Untersuchungen bei Stoffwechselge-sundend und Diabetiken. Klin Wochenchr 1955; 33: 729-730
33. Shih W, Hines WH, Neilson EG. Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int 1988; 33: 1113-1118
34. Baroni EA, Costa RS, DA Silva CGA, Coimbra TM. Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Nephron 2000; 84: 248-257
35. Coimbra TM, Janssen U, Gröne HJ et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182
36. Volpini RA, Balbi APC, Costa RC, Coimbra TM. Increased expression of p38 mitogen-activated protein kinase is related to acute renal lesions induced by gentamicin. Braz J Med Biol Res 2006; 39: 817-823
37. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501
38. Liu J, Yeo HC, Doniger SJ, Ames BN. Assay of aldehydes from lipid peroxidation: Gas chromatography-mass spectrometry compared to thiobarbituric acid. Anal Biochem 1997; 245: 161-166
39. Rodrigues M, Barbosa F,Jr, Perussi JR. Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro. Braz J Med Biol Res 2004; 37: 591-599
40. McGahan MC, Tyczkowska KT. The determination of platinum in biological materials by electrothermal atomic absorption spectroscopy. Spectrochimica Acta 1987; 42B: 665-668
41. Daugaard G, Holstein-Rathlou NH, Leyssac PP. Effect of cisplatin on proximal convoluted and straight segments of the rat kidney. J Pharmacol Exp Ther 1988; 244: 1081-1085
42. Kishore BK, Krane CM, Di Iulio D, Menon AG, Cacini W. Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int 2000; 58: 701-711
43. Krilleke D, Ucur E, Pulte D, Schulze-Osthoff K, Debatin KM, Herr I. Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis. Int J Cancer 2003; 107: 520-527
44. Vasilevskaya IA, Rakitina TV, O'Dwyer PJ. Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. Mol Pharmacol 2004; 65: 235-243
45. Watanabe J, Nishiyama H, Matsui Y et al. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. Oncogene 2006; 25: 2500-2508
46. Otmanns U, Issa R, Sukkar MB, John M, Fan-Chung K. Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells. Brit J Pharm 2003; 139: 1228-1234
47. Han Z, Boyle DL, Chang L et al. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108: 73-81
48. Bennett BL. c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur Respir J 2006; 28: 651-661
49. Shigematsu H. Renal damage and macrophages. J Toxicol Pathol 1994; 7: 1-8
50. Shimizu MHM, Coimbra TM, Araujo M, Menezes LF, Seguro AC. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; 68: 2208-2217
51. Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR. Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules. Am J Physiol (Renal Fluid Electrolyte Physiol) 1990; 258: F1181-F1187